MiR-892 was upregulated and has been shown to activate NF-kB, with a reduction in cellular proliferation in tumour models (53), and may have an effect on angiogenesis but its role in the development or protection against diabetes related complications needs clarification. The gene discussed is NFKB1; the disease is neoplasm.